Today’s Biden-Netanyahu Call Could Get Tense After WCK Airstrike—But Key Allies Want More Than Tough Talk
$1.2 Billion Powerball Jackpot Is Now The Biggest Of 2024—Here’s What The Winner Could Take Home After TaxesDrug manufacturer Amylyx Pharmaceuticals announced on Thursday plans to remove Relyvrio from the market after lackluster results from a phase III trial, leaving only two other ALS drugs on the market.The process to remove the drug from the market in both Canada and the U.S.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
Controversial ALS Drug May Be Pulled from Market After Disappointing Trial ResultsFollowing disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. Amylyx Pharmaceuticals is considering voluntarily withdrawing the drug, Relyvrio/Albrioza, after it failed to help patients in a large follow-up study. The company has decided to pause promotion of the medication and will announce their plans for the drug in the next two months.
출처: MedicineNet - 🏆 575. / 51 더 많은 것을 읽으십시오 »
ALS drug will be pulled from US market after study showed patients didn't benefitTexas Monthly's bracket narrowed the list to a Final Four - and then a winner.
출처: wfaa - 🏆 543. / 51 더 많은 것을 읽으십시오 »
ALS drug will be pulled from US market after study showed patients didn't benefitHigh temperatures remain in the 80s.
출처: KENS5 - 🏆 608. / 51 더 많은 것을 읽으십시오 »